Medicine
Zurzuvae 30 mg capsule
Zurzuvae 30 mg capsule is a prescription medicine containing Zuranolone for oral use, marketed by Biogen MA, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature 20°C to 25°C (68°F to 77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Zuranolone
- Brand
- Zurzuvae
- Strength
- 30 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- Biogen MA
- Manufacturer
- Biogen MA
- Origin register
- US FDA, United States
- Storage
- Store at room temperature 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N06A Antidepressant
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 October 2023
- Identifiers
- RxCUI 2669910, 2669916, 2669918 +3DailyMed set ID f18e53b0-d0bb-422d-8de7-ab64b7292b29NDC 64406-031Application NDA217369
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 14 capsule in 1 bottle | 64406-031-01 | Biogen MA | 31 October 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Zuranolone
Clinical summary
Zuranolone is a neuroactive steroid gamma-aminobutyric acid A receptor positive modulator indicated for the treatment of postpartum depression (PPD) in adults. It is available as capsules for oral use. MedsAcross supplies Zuranolone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ZuranoloneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ZURZUVAE prescribing information (Biogen MA) · U.S. National Library of Medicine, DailyMed
- Zurzuvae: European public assessment report (EPAR) · European Medicines Agency
Need Zurzuvae 30 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.